Search results

• Life Sciences sustainability review

  Sustainability is embedded in our business strategy, shaping innovation and meeting customer expectations. In Life Sciences, it drives impact, performance and long-term value.

• Chief Executive sustainability statement

  “By thinking boldly, acting with purpose, and living our values every day, we are bringing Smart science to improve lives™ to life and working hard to achieve our commitment to be the most sustainable supplier of innovative ingredients by 2030, delivering solutions to tackle some of the world’s biggest challenges”

• Why invest in Croda?

  Discover why investing in Croda offers long-term growth, innovation-led performance, and sustainable value across global specialty chemicals markets.

• 2025 Annual Report

  Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.

• Chairs statement 2025

  A message from the Chair, Danuta Gray, highlighting the company’s performance, strategic progress, governance priorities, and outlook for sustainable growth in the year ahead.

• Chief Executive's Statement 2025

  An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Behind the Science

  Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

• Meet the expert: Dhanila Varkey, Applications Team Lead

  Discover how Croda’s applications expert Dhanila Varkey is using nanotechnology to improve targeting, absorption and effectiveness in topical and transdermal drug delivery.

• Meet the expert: Will Small, Research & Technology Specialist

  Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

• Meet the expert: Chris Wells, Applications Team Lead

  Meet the expert: Chris Wells, Applications Team Lead

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Croda Foundation

  Introduction to the Croda Foundation, the independently managed, philanthropic arm of Croda International.

• Greater China

  Croda has been present in China since 1993.